Exploring the economic landscape of ureteric stones: impact of age and gender on direct healthcare costs.
Costs
Renal colic
Urolithiasis
Journal
Urolithiasis
ISSN: 2194-7236
Titre abrégé: Urolithiasis
Pays: Germany
ID NLM: 101602699
Informations de publication
Date de publication:
31 May 2024
31 May 2024
Historique:
received:
04
01
2024
accepted:
21
05
2024
medline:
31
5
2024
pubmed:
31
5
2024
entrez:
31
5
2024
Statut:
epublish
Résumé
To assess whether age or gender affects ureteric stone management costs, in patients presenting to the Emergency Department (ED) with CT proven ureteric stones. A retrospective examination was conducted on patients admitted to the ED who were diagnosed with a ureteric stone through CT scans. Data encompassing clinical, laboratory, and imaging parameters were gathered, alongside information on admissions, ED readmissions, surgical procedures, and the overall treatment cost. Comparative analyses were performed on various cost rates in relation to different stone parameters, patient clinical presentations, laboratory results, and personal histories of urolithiasis. From January 2018 to January 2020, 805 patients underwent abdominal CT scans at a single institution's ED and were diagnosed with ureteric stones. Among them, 773 patients met the inclusion criteria, with 78% (609) being males and 22% (169) females. The mean ages for males and females were 49.4 (SD 14.4) and 51.6 (SD 15.7), respectively (p = 0.08). Treatment costs exhibited a direct relationship with age, amounting to 4,025, 5,116, 6,058, and 9,225 US dollars (USD) in the 18-30, 31-50, 51-70, and over 70 age groups, respectively. Female gender was associated with higher treatment costs, averaging 6,831 USD, compared to 5,450 USD in males (p = 0.03). However, there were no significant differences between genders in terms of the type of surgical procedure (p = 0.4) or hospital stay duration (p = 0.1). Age and gender exerted a significant impact on treatment costs, revealing that advanced age and female gender were both correlated with higher direct treatment costs in the care of ureteric stones.
Identifiants
pubmed: 38819676
doi: 10.1007/s00240-024-01584-1
pii: 10.1007/s00240-024-01584-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823. https://doi.org/10.1046/J.1523-1755.2003.00917.X
doi: 10.1046/J.1523-1755.2003.00917.X
pubmed: 12675858
Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173:848–857. https://doi.org/10.1097/01.JU.0000152082.14384.D7
doi: 10.1097/01.JU.0000152082.14384.D7
pubmed: 15711292
EAU Guidelines Urolithiasis | Uroweb. https://uroweb.org/guideline/urolithiasis/ . Accessed 4 Dec 2020
Jendeberg J, Geijer H, Alshamari M et al (2017) Size matters: the width and location of a ureteral stone accurately predict the chance of spontaneous passage. Eur Radiol 27:4775–4785. https://doi.org/10.1007/S00330-017-4852-6
doi: 10.1007/S00330-017-4852-6
pubmed: 28593428
pmcid: 5635101
Lotan Y, Gettman MT, Roehrborn CG et al (2002) Management of Ureteral Calculi: a cost comparison and decision making analysis. J Urol 167:1621–1629. https://doi.org/10.1016/S0022-5347(05)65166-X
doi: 10.1016/S0022-5347(05)65166-X
pubmed: 11912376
Bensalah K, Pearle M, Lotan Y (2008) Cost-effectiveness of Medical Expulsive Therapy using alpha-blockers for the treatment of distal Ureteral stones. Eur Urol 53:411–419. https://doi.org/10.1016/J.EURURO.2007.09.012
doi: 10.1016/J.EURURO.2007.09.012
pubmed: 17889988
Canvasser NE, Alken P, Lipkin M et al (2017) The economics of stone disease. World J Urol 35:1321–1329. https://doi.org/10.1007/S00345-017-2003-Y
doi: 10.1007/S00345-017-2003-Y
pubmed: 28108799
Lotan Y (2009) Economics and cost of care of Stone Disease. Adv Chronic Kidney Dis 16:5–10. https://doi.org/10.1053/j.ackd.2008.10.002
doi: 10.1053/j.ackd.2008.10.002
pubmed: 19095200
Roberson D, Sperling C, Shah A, Ziemba J (2020) Economic considerations in the management of Nephrolithiasis. Curr Urol Rep 21. https://doi.org/10.1007/S11934-020-00971-6
McCarthy J-P, Skinner TAA, Norman RW (2011) Urolithiasis in the elderly. Can J Urol 18:5717–5720
pubmed: 21703047
Arampatzis S, Lindner G, Irmak F et al (2012) Geriatric urolithiasis in the emergency department: risk factors for hospitalisation and emergency management patterns of acute urolithiasis. BMC Nephrol 13:1–6. https://doi.org/10.1186/1471-2369-13-117/TABLES/3
doi: 10.1186/1471-2369-13-117/TABLES/3
Krambeck AE, Lieske JC, Li X et al (2013) Effect of age on the clinical presentation of Incident Symptomatic Urolithiasis in the General Population. J Urol 189:158. https://doi.org/10.1016/J.JURO.2012.09.023
doi: 10.1016/J.JURO.2012.09.023
pubmed: 23164393
Chauhan V, Eskin B, Allegra JR, Cochrane DG (2004) Effect of season, age, and gender on renal colic incidence. Am J Emerg Med 22:560–563. https://doi.org/10.1016/J.AJEM.2004.08.016
doi: 10.1016/J.AJEM.2004.08.016
pubmed: 15666261
Golomb D, Dave S, Berto FG et al (2022) A population-based, retrospective cohort study analyzing contemporary trends in the surgical management of urinary stone disease in adults. Can Urol Association J 16:112. https://doi.org/10.5489/CUAJ.7474
doi: 10.5489/CUAJ.7474
Scales CD, Curtis LH, Norris RD et al (2007) Changing gender prevalence of stone disease. J Urol 177:979–982. https://doi.org/10.1016/J.JURO.2006.10.069
doi: 10.1016/J.JURO.2006.10.069
pubmed: 17296391